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Dopaminergic (DA) neurons of the ventral midbrain (VM) play vital roles in the regulation of voluntary
movement, emotion and reward. They are divided into the A8, A9 and A10 subgroups. The development
of the A9 group of DA neurons is an area of intense investigation to aid the generation of these neurons
from stem cell sources for cell transplantation approaches to Parkinson's disease (PD). This review
discusses the molecular processes that are involved in the identity, speciﬁcation, maturation, target
innervation and survival of VM DA neurons during development. The complex molecular interactions of a
number of genetic pathways are outlined, as well as recent advances in the mechanisms that regulate
subset identity within the VM DA neuronal pool. A thorough understanding of the cellular and molecular
mechanisms involved in the development of VM DA neurons will greatly facilitate the use of cell
replacement therapy for the treatment of PD.
& 2013 Elsevier Inc. All rights reserved.Introduction
In the adult CNS, almost 75% of all dopaminergic neurons reside
in the ventral midbrain (VM), with 400,000–600,000 found in the
human VM and 20,000–30,000 in the mouse VM (Blum, 1998;
German et al., 1983; Pakkenberg et al., 1991). During embryonic
development, these DA neurons are generated in the ﬂoor plate
region of the mesencephalon (Ono et al., 2007), and give rise to
three distinct clusters of VM DA neurons which ultimately develop
into anatomically and functionally distinct entities termed the A8,
A9 and A10 groups. The A9 cluster gives rise to the substantia
nigra pars compacta (SNc), whose neurons project to the dorsal
striatum via the nigrostriatal pathway. These neurons and their
striatal projections are required for the control of voluntary
movement, and the loss of these neurons is the pathological
hallmark of Parkinson's disease (PD), which is a neurodegenerativell rights reserved.
-derived neurotrophic factor;
rter; D/V, dorso-ventral;
st growth factor 8; Fzd,
ctor; MFB, medial forebrain
neuroepithelial/neural stem
etrorubal ﬁeld; Shh, sonic
tyrosine hydroxylase; VM,
ntal area; VZ, ventricular
, Ćg.okeeffe@ucc.ie (G.
.disorder characterised by impaired motor function (Lees et al.,
2009; Toulouse and Sullivan, 2008). The other groups of DA
neurons, the A10 and A8 clusters, develop into the ventral
tegmental area (VTA) and the retrorubal ﬁeld (RRF), respectively,
whose neurons innervate the ventral striatum and the prefrontal
cortex via the mesocorticolimbic system, and are involved in the
regulation of emotion and reward (Tzschentke and Schmidt,
2000). Altered/defective neurotransmission of the mesocortico-
limbic DA system has been associated with the development of
schizophrenia, drug addiction and depression (Meyer-Lindenberg
et al., 2002; Robinson and Berridge, 1993).
Interestingly, the A9 group of SNc DA neurons, which undergo
progressive degeneration in PD, are particularly vulnerable to cell
death in comparison to the other VM DA neuronal populations
(Alavian et al., 2008; Betarbet et al., 2000; Farrer, 2006; McNaught
et al., 2004). The anatomical, functional and apparent sensitivity
differences between these three populations of VM DA neurons
likely results from subtle developmental differences during their
ontogeny. However, little is known regarding the molecular
mechanisms that regulate the phenotypic and functional diversi-
ties between these VM DA neuronal populations. Given the
involvement of A9 DA neurons in PD, an intensive research effort
over the last ﬁve decades has focused on identifying the molecules
and mechanisms that regulate their development. This informa-
tion is vital to advance efforts to generate SNc DA neurons from
stem cells for application in cell replacement therapy for PD.
Through the mutation of speciﬁc genes, and the subsequent
analysis of VM DA neurogenesis and development, a number of
molecular pathways have been shown to play key roles in the
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‘normal’ developmental programme that regulates VM DA neuro-
genesis, including the cellular and molecular determinants
involved in their regional speciﬁcation, induction, differentiation
and maturation.Early patterning of the ventral mesencephalon
The ﬁrst key steps in VM DA generation are the early patterning
events which lead to the formation of the VM region. During
gastrulation, the dorsal ectoderm is restricted towards a neural
fate in response to signals arising from the Speamann organiser
(Harland, 2000; Hemmati-Brivanlou and Melton, 1997; Liu and
Niswander, 2005). The resulting neural plate is then subdivided
into restricted domains and subsequently closes to form the neural
tube, which is speciﬁed by graded signals along the anterior–
posterior (A/P) and dorso-ventral (D/V) axes (Puelles, 2001; Simon
et al., 1995; Ulloa and Briscoe, 2007). The development of the VM
region relies on appropriate A/P and D/V patterns of gene expres-
sion which are regulated by signals arising from two key structures
in the early embryo: the ﬂoor plate of the midbrain and the
isthmus organiser. Organisation of the VM region is initiated upon
formation of these signalling centres.
The ﬂoor plate is present along the length of the neural tube
and secretes the sonic hedgehog (Shh) signalling protein from
around embryonic day (E) 8.5 onwards in the mouse (Echelard
et al., 1993; Ho and Scott, 2002; Hynes et al., 1995a). Interestingly,
the spatiotemporal expression pattern of Shh in the VM has been
shown to contribute to the diverse populations of VM DA neurons,
with the ‘early medial pool’ giving rise primarily to VTA, and very
few SNc, DA neurons and the ‘later intermediate pool’ giving rise
to DA neurons of all three subgroups, but largely contributing to
the SNc (Joksimovic et al., 2009a). In the ﬂoor plate, the bHLH
(basic helix–loop–helix) transcription factor Hes1 (also expressed
by the isthmus organiser) has been shown to suppress proneural
gene expression and induce cell cycle exit (Baek et al., 2006; Ono
et al., 2010). Null mutation of Hes1 results in a transient increase in
the number of VM DA neurons between E11.5 and E12.5, followed
by a signiﬁcant reduction in their number from E13.5, compared to
the wild type (Kameda et al., 2011). Interestingly, another bHLH
transcription factor expressed in the ﬂoor plate, Nato3, has been
shown to repress Hes1 expression, and mutation of Nato3 has been
shown to result in a reduction in the number of VM DA neurons
generated due to unchecked Hes-1-mediated suppression of
proneural genes and the induction of cell cycle arrest (Ono et al.,
2010).
The isthmus organiser is a unique signalling centre that
separates the midbrain from the hindbrain and is necessary for
the development of both of these brain regions (Liu and Joyner,
2001; Rhinn and Brand, 2001). The correct positioning of the
isthmus organiser at the midbrain-hindbrain boundary is depen-
dent on the mutual repression of two opposing homeodomain
transcription factors: Otx2 and Gbx2 (Martinez-Barbera et al.,
2001). Otx2 is expressed in the forebrain and midbrain of the
developing anterior neural tube (Acampora et al., 1997; Matsuo
et al., 1995; Simeone et al., 1992), while Gbx2 is expressed more
posteriorly in the anterior hindbrain (Wassarman et al., 1997).
Gbx2 expression at the posterior border limits Otx2 expression
which creates the sharp boundary between the midbrain and the
hindbrain (Millet et al., 1999).
Fibroblast growth factor 8 (FGF8) is a diffusible factor secreted
by the isthmus organiser (Rhinn and Brand, 2001), from around E8
until at least E12.5 in the mouse midbrain-hindbrain boundary
(Crossley and Martin, 1995). Surprisingly, although Otx2 and Gbx2
are critical for the correct positing of the isthmus organiser, theyare not required for the expression of FGF8, or for the induction of
other isthmus organiser-genes, however they are essential for the
correct positioning of the expression domains of these genes
(Brodski et al., 2003; Liu and Joyner, 2001). This is highlighted
by studies showing that if the position of the isthmus organiser is
moved caudally as a result of ectopic Otx2 expression in hindbrain,
there is an increase in the number of VM DA neurons (Brodski
et al., 2003). Similarly if its position is moved rostrally by depleting
Otx2 in the midbrain, there is a decrease in the number of VM DA
neurons (Brodski et al., 2003), demonstrating the critical impor-
tance of isthmus organiser positioning for normal VM DA
generation.
As Otx2- and Gbx2-dependent sharpening of the borders of the
isthmus is occuring, a second group of transcription factors begin
to be expressed in the isthmus organiser. These include the paired
box gene Pax2 (Urbanek et al., 1997), the lim-homeodomain factor
Lmx1b (Adams et al., 2000; Smidt et al., 2000), the secreted
glycoprotein Wnt1 (Adams et al., 2000; Crossley and Martin,
1995, Davis and Joyner, 1988; Wilkinson et al., 1987), and
Engrailed-1 (En1) (Davis and Joyner, 1988). Of these, Pax2 is
required for the induction of FGF8 expression by the isthmus,
whereas Wnt1 and En1 function cooperatively with Otx2 and Gbx2
to further reﬁne the position of the expression domain of FGF8 at
the isthmus (Ye et al., 2001).
Shortly after the induction and positioning of FGF8 expression,
Engrailed-2 (En2) and Pax5 start to be expressed in the midbrain-
hindbrain boundary. These genes play critical roles in the regional
speciﬁcation of the VM, and homozygous mutant mice null for
Otx2 (Acampora et al., 1995; Ang et al., 1996),Wnt1 (McMahon and
Bradley, 1990; Prakash et al., 2006), Pax2 and Pax5 (double
mutant) (Schwarz et al., 1997), En1 and En2 (double mutant) (Liu
and Joyner, 2001; Simon et al., 2001), or Lmx1b (Smidt et al., 2000)
all display major VM defects, including partial or total loss of VM
DA neurons (see Table 1).Identity of ventral midbrain dopaminergic neural precursors
Once the appropriate patterning of the VM region has occurred, a
developmental programme involving a sequential pattern of gene
expression establishes the identity of VM DA neural precursors (NPs)
that ultimately generate VM DA neurons (Fig. 1). The identity of these
VM DA NPs has been the focus of intensive research in recent years,
largely due to their potential to be used as a cell source to generate
DA neurons for cell replacement therapy in PD (Kim, 2011; Morizane
et al., 2008; Toulouse and Sullivan, 2008).
The origin of VM DA NPs has been debated for many years, with
regions such as the diencephalon (Marin et al., 2005), isthmus
(Marchand and Poirier, 1983) and VM basal plate (Hynes et al.,
1995a, 1995b) emerging as potential candidates. Despite this
research, the precise identity of VM DA NPs remained elusive
until recently, when a study showed that ﬂoor plate cells in the
murine VM become neurogenic and subsequently give rise to DA
neurons (Ono et al., 2007). This discovery was surprising as the
ﬂoor plate was thought to consist of specialised non-neurogenic
glial type cells that were largely involved in ventralizing the neural
tube, mainly by secreting Shh (Fuccillo et al., 2006; Jessell, 2000;
Placzek and Briscoe, 2005). This role in ventralisation seems to
remains the main function for ﬂoor plate cells caudal to the
midbrain, as the hindbrain ﬂoor plate has been shown to be
non-neurogenic (Joksimovic et al., 2009b; Ono et al., 2007).
However, the VM ﬂoor plate is different to its caudal counterparts
and attains neurogenic potential. Ono et al. (2007) demonstrated
that Otx2, which is critical for the positioning of the isthmus
organiser, is also essential for the neurogenic potential of VM ﬂoor
Table 1
Genetic mutations affecting the development of VM DA neurons.
Mutation(s) Effect(s) on DA development Reference(s)
Otx2 −/− Loss of VM DA neurons (midbrain absent) Acampora et al. (1995), Ang et al. (1996)
Wnt1 −/− Severe reduction in VM DA neurons generated McMahon and Bradley (1990), Prakash et al. (2006)
Pax2 −/−: Loss of VM DA neurons (midbrain absent) Schwarz et al. (1997)
Pax5 −/−
En1 −/−: VM DA neurons lost by E14 via apoptosis Alberi et al. (2004), Liu and Joyner (2001), Simon et al.
(2001)En2 −/−
Lmx1b −/− Substantial reduction in VM DA neurons generated, and disappearance of Pitx3− VM
DA neurons by birth
Deng et al. (2011), Smidt et al. (2000)
Hes1 −/− Transient increase (∼E12) in VM DA neurons, followed by their signiﬁcant reduction
(from E13.5). Dorsal migration and hindbrain invasion
Kameda et al. (2011)
Nato3 −/− Reduction in VM DA neurons generated Ono et al. (2010)
FGFR −/− Deﬁcit of VM DA neurons Lahti et al. (2012), Saarimaki-Vire et al. (2007)
FGF2 −/− Peri-/post-natal increase in VM DA neurons Ratzka et al. (2012)
Lmx1a −/− Substantial reduction in VM DA neurons generated Deng et al. (2011), Ono et al. (2007)
En1Cre/+; Reduction in VM DA neurons due to failure of VM DA NP induction Omodei et al. (2008), Puelles et al. (2004)
Otx2ﬂox/ﬂox
Ngn2 −/− Reduction in mature VM DA neurons generated Kele et al. (2006)
Oc1 −/−: Reduction in VM DA neurons generated Chakrabarty et al. (2012)
Oc2 −/−
Gli1 −/−: Deﬁcient VM DA neurogenesis (more severe than Gli2 −/−) Park et al. (2000)
Gli2 −/−
Gli2 −/− Deﬁcient VM DA neurogenesis Park et al. (2000)
Lmx1a −/−; ShhCre/+;
Lmx1b −/−
Substantial reduction in VM DA neurons generated (more severe than Lmx1a −/−) Yan et al. (2011)
Lmx1a −/−: Lmx1b
+/−
Substantial reduction in the generation of VM DA neurons (more severe than
Lmx1a −/−)
Deng et al. (2011)
Lrp6 −/− Delayed differentiation of VM DA neurons Castelo-Branco et al. (2010), Pinson et al. (2000)
Fzd3 −/−: Deﬁcient VM DA neurogenesis (severe midbrain defects) Stuebner et al. (2010)
Fzd6 −/−
Fzd3 −/− Transient reduction in VM DA neuron generated Stuebner et al. (2010)
Wnt2 −/− Reduction in VM DA neurons generated Sousa et al. (2010)
β-catenin (Th-IRES-
Cre; β-CtnEx3/+
mutant)
Reduction in VM DA neurogenesis Tang et al. (2009)
Dkk1 −/− Severe loss of VM DA neurons Ribeiro et al. (2011)
L1 −/− Positional abnormalities of VM DA neurons Demyanenko et al. (2001)
Reelin −/− Failure of VM DA neuron lateral migration Nishikawa et al. (2003)
DCC −/− Aberrant VM DA neuron migration, dorsal shifting of ventral striatal DA projections,
aberrant crossing of MFB ﬁbres at caudal diencephalic midline, and reduction of
prefrontal cortex DA innervation
Xu et al. (2010)
Ebf1 −/− Impaired tangential migration of VM DA neurons Yin et al. (2009)
Nurr1 −/− Lack TH, AADC, VMAT2 and DAT expression in VM DA neurons, and their
subsequently loss
Castillo et al. (1998), Filippi et al. (2007), Saucedo-
Cardenas et al. (1998), Smits et al. (2003), Wallen et al.
(1999)
Nurr1 −/− (at late
stage of DA dev.)
VM DA neuron degeneration (snc more vulnerable) Kadkhodaei et al. (2009)
FoxA2 −/− Increase in numbers of Nurr1+ TH− neurons in VM Ferri et al. (2007)
FoxA2 +/− Aged mice develop PD-like symptoms and pathologies Kittappa et al. (2007)
Pitx3 −/− Deﬁcit of snc DA neurons from E12.5 (VTA largely unaffected) Hwang et al. (2003), Nunes et al. (2003), Smidt et al.
(2004), Van Den Munckhof et al. (2003)
En1 +/−: Progressive degeneration of VM DA neurons (8–24 weeks) Sonnier et al. (2007)
En2 +/+
En1 +/−: Progressive degeneration of VM DA neurons (more pronounced in snc) Sgado et al. (2006), Sonnier et al. (2007)
En2 −/−
Nkx2.1 −/− Aberrant crossing of MFB ﬁbres at caudal diencephalic midline Kawano et al. (2003)
DCC +/− Increased branching of VM DA ﬁbres in prefrontal cortex Manitt et al. (2011)
Pbx1a −/− Partial misrouting of VM DA ﬁbres Sgado et al. (2012)
Pax6 −/− Dorsal deﬂection of MFB ﬁbres in the diencephalon Vitalis et al. (2000)
Slit1 −/−: Aberrant crossing of MFB ﬁbres at caudal diencephalic midline Bagri et al. (2002), Dugan et al. (2011)
Slit2 −/−
Robo1 −/−: Aberrant crossing of MFB ﬁbres at caudal diencephalic midline, and abnormal dorsal
trajectories of VM DA ﬁbres
Dugan et al. (2011), Lopez-Bendito et al. (2007)
Robo2 −/−
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determining the overall structure of the VM region.
However, although the region from which VM DA NPs arise
has been determined, the speciﬁc ﬂoor plate cell type which is a
DA NP cell remains to be identiﬁed. Fate-mapping studies using a
marker for radial glia-speciﬁc marker GLAST demonstrated
that radial glial-like cells in the ﬂoor plate of the mouse VM were
DA NPs (Bonilla et al., 2008). Shortly thereafter, a similar study
using human VM tissue demonstrated that DA NPs in theVM ﬂoor plate showed radial glial characteristics, that is they
expressed the radial glial markers, vimentin and BLBP, and
displayed a radial morphology (Hebsgaard et al., 2009). VM DA
neurons therefore arise from ﬂoor plate radial glial-like NPs. The
radial-glial origin of DA neurons should not be considered peculiar
due to its departure from the classical view of radial glia as a
supportive glial cell type. Indeed, the separate identities of radial
neuroectodermal stem cells and radial glial cells is regularly
challenged in the literature, with some authors suggesting that
Fig. 1. Molecular factors involved in the development of VM DA neurons.Molecular interactions in the genesis of VM DA neurons: The sequence of appearance (see time-course
arrow) of each of the factors involved in VM DA neuronal development, and their effects on each other. (Note: the molecules in black text are not shown at the time point at
which they appear.) The arrows denote the effect on expression: purple¼positive regulation, green¼autoregulatory loop, orange¼cooperative regulation, and
black¼negative regulation. The factors are colour-coded as per their role (listed above molecules). Otx2, Gbx2, En1/2, Lmx1b, Wnt1 and Pax2/5 play vital roles in the
establishment of the midbrain/hindbrain region, including the isthmus organizer and VM ﬂoor plate, and the majority also play direct roles in VM DA neurogenesis. The
diffusible signalling factors FGF8, Shh and Wnt1 induce VM DA neurogenesis in radial glial-like ﬂoor plate cells, through the induction of FoxA2, Lmx1a/1b, and Msx1
expression. Two autoregulatory loops, Shh–FoxA2 and Wnt1–Lmx1a, contribute to this process, with Hes1 being involved in the Shh–FoxA2 autoregulatory loop, and Lmx1b
functioning cooperatively with Lmx1a. The expression of Nurr1 and Pitx3 promotes the differentiation of VM DA NPs into post-mitotic neurons. Nurr1 induces the expression
of proteins that are key to the neurotransmitter phenotype of VM DA neurons. A number of factors facilitate the induction of TH by Nurr1 (listed in orange), and Pitx3 has
been shown to cooperatively regulate a number of important genes involved in VM DA neurogenesis with Nurr1.
S.V. Hegarty et al. / Developmental Biology 379 (2013) 123–138126they are in fact the same cell type (Kriegstein and Alvarez-Buylla,
2009).Induction of a dopaminergic phenotype in ventral midbrain
neural precursors
While the ﬂoor plate and isthmus organiser are critical deter-
minants of VM patterning, they are also crucial for the induction of
a VM DA phenotype. Their role in induction of a DA phenotype is
dependent upon the interaction of ﬂoor plate-secreted Shh and
isthmus-secreted FGF8 (Hynes et al., 1997; Ye et al., 1998).
FGF8
The mechanism by which FGF8 regulates VM DA development
is still under investigation, however a recent study suggested that
FGF8 is required to induce the correct patterning of VM DA NPs, as
the loss of FGFRs (FGF receptors) resulted in altered patterning of
the VM and failure of VM DA neuron maturation, with the DA
domain adopting diencephalic characteristics (Lahti et al., 2012). In
support of this, a similar study that mutated the FGFRs reported a
reduction in the generation of VM DA NPs, and a disturbance in
the maturation of VM DA neurons (Saarimaki-Vire et al., 2007).
Another FGF, FGF2, has been shown to function in the regulation of
SNc DA NPs proliferation, and also in the developmental cell death
of mature SNc DA neurons (Ratzka et al., 2012).
Sonic hedgehog (Shh) signalling and Lmx1 expression
The ﬁrst sign of a DA phenotype in VM NPs is the initiation of
expression of two key determinants of VM DA cell fate, the lim-
homeodomain factor Lmx1a and the homeodomain transcription
factorMsx1, at ∼E9 in the mouse (Alavian et al., 2008). Shh induces
the expression of Lmx1a, which subsequently induces theexpression of its downstream effector Msx1 (Andersson et al.,
2006). The overexpression of Lmx1a in the anterior VM results in
the ectopic generation of DA neurons, while reduced expression
results in a loss of VM DA neurons (Andersson et al., 2006).
Additionally, null mutation of Lmx1a or the spontaneous mutation
of Lmx1a in dreher mice results in substantial reductions in the
numbers of VM DA neurons generated (Deng et al., 2011; Ono
et al., 2007). Lmx1a expression is maintained in post-mitotic VM
DA neurons until postnatal day (P) 180 in mice (Zou et al., 2009);
however Msx1 expression is conﬁned to VM DA NPs (Andersson
et al., 2006; Failli et al., 2002). This is surprising considering that
Lmx1a is upstream of Msx1, suggesting that the post-mitotic
repression of Msx1 expression somehow overrides the inductive
effect of Lmx1a. Msx1 contributes to DA neurogenesis by inducing
the expression of the proneural gene, neurogenin (Ngn) 2, and thus
neuronal differentiation. Ngn2 expression in VM NPs also appears
to be under the control of Otx2 expression, as conditional Otx2
mutant mice display a loss of Ngn2 expression in DA NPs (Vernay
et al., 2005). This ﬁnding is not surprising, considering that Otx2
induces the expression of Lmx1a in VM ﬂoor plate cells, suggesting
that the loss of Ngn2 expression in the Otx2 knockout mouse is due
to a failure of Lmx1a induction and subsequently Msx1 expression,
rather than a direct effect on Ngn2 expression, but this remains to
be determined (Ono et al., 2007). This suggestion is supported by
recent ﬁndings showing that in the absence of Otx2, VM NPs fail to
activate the expression of Lmx1a, Msx1 and Ngn2, and therefore
largely fail to differentiate into VM DA neurons (Omodei et al.,
2008).
Support for the role of Ngn2 in DA induction comes from
studies showing that loss of Ngn2 in mice results in a severe
reduction in the expression of post-mitotic VM DA markers Nurr1
and tyrosine hydroxylase (TH) (discussed later), demonstrating its
importance in the generation of mature VM DA neurons (Kele
et al., 2006). However, the role of Ngn2 is likely to be generally
proneural, rather than speciﬁc for VM DA neuronal differentiation.
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but not a DA phenotype in cultured VM NPs (Kim et al., 2007).
These data suggest the existence of a developmental programme
consisting of an inductive effect of ﬂoorplate-secreted Shh on
Lmx1a expression which subsequently induces the expression of
Msx1, which in turn induces the expression of Ngn2 which is
required for neuronal differentiation of VM DA NPs. How and
where Otx2 ﬁts into this cascade is unclear, but it is known that
Otx2 is required for the expression of Lmx1a. It has yet to be
determined whether this is a parallel pathway cooperating with
Shh or whether Otx2 is a master regulator of Shh-induced Lmx1a
expression. In support of a role of Otx2 as a master regulator,
studies involving the conditional knockout of Otx2 in the midbrain
have suggested that Otx2 controls the fate of VM progenitors
through the repression of Nkx2.2 and maintenance of Nkx6.1
expression (Puelles et al., 2004). FoxA2, involved in a feedback
loop with Shh (discussed later), induces Lmx1a expression and also
inhibits Nkx2.2 (Lin et al., 2009). It is possible that Otx2 functions
via a similar pathway to FoxA2, or indeed that FoxA2 may function
downstream of Otx2 and Shh in the regulation of Lmx1a and
Nkx2.2 expression during VM DA neurogenesis.
Interestingly, a recent genome-wide gene expression proﬁling
study has expanded the regulatory role of Lmx1a in this process by
identifying novel transcription factors involved in the generation
of the VM DA neuronal ﬁeld. The Oc transcription factors, Oc1, 2
and 3, display similar expression proﬁles to that of Lmx1a in the
developing VM, and their loss resulted in diminished generation of
VM DA neurons (Chakrabarty et al., 2012). Whether these Oc
transcription factors are regulated by Lmx1a, which is plausible
given their overlapping expression patterns, or whether they act in
parallel to regulate neuronal differentiation in the VM, will be an
important question for future research.
Similar to Lmx1a, the related protein Lmx1b has also been
shown to promote VM DA neurogenesis (Deng et al., 2011; Lin
et al., 2009; Yan et al., 2011). Lmx1a and Lmx1b are co-expressed in
VM DA NPs, and have been shown to mediate the initial steps of
NP DA speciﬁcation (Andersson et al., 2006; Smidt et al., 2000).
Furthermore, Lmx1a and Lmx1b are co-expressed in the P0 VM,
suggesting that they may function in the maturation of VM DA
neurons also (Zou et al., 2009). Similar to Lmx1a, Lmx1b can induce
the ectopic production of VM DA neurons when ectopically
expressed (Nakatani et al., 2010), and its loss results in a sub-
stantial reduction in the number of VM DA neurons (Deng et al.,
2011; Smidt et al., 2000). A recent study using conditional knock-
out of Lmx1a and Lmx1b in mice demonstrated that Lmx1a and
Lmx1b function cooperatively to regulate the proliferation of VM
DA NPs and Ngn2 expression (Yan et al., 2011). This suggestion is
supported by studies on Lmx1a null mice carrying one mutant
Lmx1b allele (as double null mutations are embryonically lethal)
which found that Lmx1a and Lmx1b function cooperatively in the
generation of VM DA neurons. This study also showed that Lmx1b
is involved in the generation of ocular motor neurons and red
nucleus neurons in the VM (Deng et al., 2011) and it has been
suggested that Lmx1b partially compensates for Lmx1a function in
dreher mice, as only 46% of VM DA neurons are lost in these
mutants (Ono et al., 2007). It will be important to understand
whether Lmx1b exerts its effects in precisely the same way as
Lmx1a, for example by modulating Msx1 expression or that of Oc1,
2 and 3 (Chakrabarty et al., 2012).
Sonic hedgehog (Shh) signalling and FoxA expression
Floor plate-derived Shh has been shown to play a key role in
induction of a DA phenotype by modulating the expression of the
transcriptional regulator FoxA2, a well-known ﬂoor plate marker.
The modulation of FoxA2 expression is mediated by thedownstream effector of Shh signalling, Gli1 (Hynes et al., 1997).
Gli1 expression is upregulated by a related molecule Gli2 (activa-
tor) in response to Shh signalling, which is required for generation
of VM DA neurons, while Gli3 (repressor) is suppressed by Shh to
allow the de-repression of FGF8 expression (Blaess et al., 2006).
Gli2 homozygous null mutants demonstrate the importance of Gli2
in inducing ventral phenotypes, as these mice display clear deﬁcits
in VM DA neurogenesis (Park et al., 2000). Loss of both Gli2 and
Gli1 resulted in a more severe phenotype (Park et al., 2000). FoxA2,
along with FoxA1, is expressed in the VM and in differentiated DA
neurons during development. Both have been shown to regulate
the expression of Ngn2 and to maintain the expression of Lmx1a
and Lmx1b, which promotes VM DA neurogenesis (Bayly et al.,
2012; Ferri et al., 2007; Lin et al., 2009). As aforementioned, Gli1
has been shown to induce the expression of FoxA2 (Hynes et al.,
1997), with FoxA2 being reported as a downstream target of Shh
signalling (Chung et al., 2009). However, FoxA2 expression pre-
cedes that of Shh in the ventral neural tube and is proposed to
regulate Shh expression (Echelard et al., 1993). These ﬁndings
likely reﬂect a regulatory feedback loop between Shh and FoxA2
expression, with Gli1 functioning downstream of Shh in this loop.
In addition to Gli1, Nato3, a bHLH transcription factor that
contributes to VM DA neurogenesis through the repression of
Hes1 (Ono et al., 2010), has been shown to integrate with the Shh–
FoxA2 regulatory feedback loop in the SN4741 dopaminergic cell
line (Nissim-Eliraz et al., in press). It has recently been suggested
that Shh is necessary and sufﬁcient for lateral ﬂoor plate genera-
tion, and necessary but not sufﬁcient for medial ﬂoor plate
generation, while FoxA2 is necessary and sufﬁcient to specify the
entire ﬂoor plate, acting through both Shh-dependent and inde-
pendent mechanisms (Bayly et al., 2012). This induction of FoxA2
expression by Shh has also been proposed to function coopera-
tively with Lmx1a and Lmx1b in the generation of DA neurons
from VM ﬂoor plate NPs (Nakatani et al., 2010). This is not
surprising, considering that Shh and FoxA2 positively regulate
Lmx1a and Lmx1b expression. FoxA2 mutant mice have a defective
ﬂoor plate, as well as notochord, and die at E9.5 (Ang and Rossant,
1994; Sasaki and Hogan, 1994), which precludes examination of
their role in DA induction. Given the recent identiﬁcation of VM
radial-glial progenitors, it will be interesting to use targeted
strategies to conditionally remove FoxA2 in the midbrain while
preserving its expression in the ﬂoor plate (possibly through the
use of GLAST-cre mice), and thus examine its inductive effect on
Shh expression and its speciﬁc role in DA neurogenesis.
Wnt signalling
The Wnt family of secreted glycoproteins have become increas-
ingly recognised as key regulators of DA neuron induction. Wnt1 is
expressed in the isthmus organiser, in an area rostral to FGF8 at
E9.5 in mice (Wilkinson et al., 1987), and is also expressed in the
developing midbrain (Davis and Joyner, 1988; Wilkinson et al.,
1987), along with other members of the Wnt family (Andersson
et al., 2008; Parr et al., 1993; Rawal et al., 2006). In vitro, Wnt1 has
been shown to regulate the proliferation of VM DA NPs and to
increase the number of DA neurons generated from these cells.
Wnt3a has been shown to enhance VM DA NP proliferation but to
inhibit their terminal DA differentiation, whereas Wnt5a regulates
the acquisition of a DA phenotype to increase DA neuronal
numbers (Castelo-Branco et al., 2003). Wnt5a in particular has
recently been demonstrated to play a role in the acquisition of a
DA phenotype in VM DA NPs in vivo (Andersson et al., 2008). The
effect of Wnt5a on DA differentiation has been suggested to be
regulated by the Rac1 guanosine exchange factor, Tiam1 (Cajanek
et al., 2013), and Wnt5a has been proposed to be an important
mediator of the DA inductive activity of VM glia (Castelo-Branco
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regulator of VM DA NP proliferation as Wnt2 null mice displayed
reductions in DA neurogenesis (Sousa et al., 2010).
Given that Wnt1 is expressed in the isthmus and developing
midbrain, it is perhaps not surprising that null mice displayed a
loss of most of the midbrain and the DA neurons therein
(McMahon and Bradley, 1990). Subsequently it was shown that
although Wnt1 null mice develop VM DA NPs, these NPs fail to
proliferate and differentiate appropriately, and the few DA neurons
that are generated are lost shortly thereafter (Prakash et al., 2006).
This is in agreement with data describing Wnt1 as a key regulator
of VM DA NPs proliferation and subsequent differentiation
(Castelo-Branco et al., 2003). There is now a large body of evidence
describing the key role of Wnt signalling in DA generation. Loss of
the Wnt receptor Lrp6 replicates some of the Wnt1 developmental
abnormalities (Castelo-Branco et al., 2010; Pinson et al., 2000).
Similarly, loss of the Wnt receptors, frizzled (Fzd) 3 and Fzd6,
severely impairs midbrain morphogenesis (Stuebner et al., 2010).
Interestingly, the null mutation of Fzd3 results in a transient
reduction in the numbers of VM DA neurons generated, similar
to that seen in the Lrp6 null mutant (Castelo-Branco et al., 2010;
Stuebner et al., 2010). Furthermore, the speciﬁc inactivation of β-
catenin, which mediates canonical Wnt signalling, mimics the
midbrain-hindbrain deﬁcits observed in Wnt1 null mice (Brault
et al., 2001; Chilov et al., 2010), suggesting that Wnt1 acts via β-
catenin during midbrain-hindbrain development.
As a result of these studies, the molecular bases of Wnt-
induced DA differentiation have been the focus of intensive
research. Wnt1 has been shown to be essential for the mainte-
nance of En1 and En2 expression (Danielian and McMahon, 1996;
McGrew et al., 1999; McMahon et al., 1992), with En1/En2 double
knockout mice displaying a similar defective VM phenotype as the
Wnt1 null mutants (Simon et al., 2001), suggesting that the effects
of loss of Wnt1 may be due to a loss of En expression. This was
subsequently conﬁrmed when it was shown that En1 was sufﬁ-
cient to rescue early midbrain deﬁcits in Wnt1 mutant mice
(Danielian and McMahon, 1996). En1 and En2 are expressed in
the ventral mesencephalon at the same time as Wnt1 (∼E8.0 in
mice), however the overlapping expression domains of these three
genes become restricted by E12 (Davis and Joyner, 1988). The
expression of Wnt1 in the En1 expression domain (En1-Wnt1
knock-in) causes a ventro-rostral and ventro-caudal expansion of
Wnt1 expression, which is usually restricted to the caudal VM
(Danielian and McMahon, 1996), and results in an expansion of the
most ventro-rostral DA cell group (Panhuysen et al., 2004). This
cell group corresponds to the SNc, thus these studies demonstrate
that this cell group is the most robustly inﬂuenced by Wnt1
signalling. En1 expression is detectable in VM DA neurons from the
time point at which they initiate their differentiation and persists
into adulthood, while En2 is only expressed in a subset of DA
neurons (Simon et al., 2001; Zhong et al., 2010).
As mentioned earlier,Wnt1 is expressed in the isthmus organiser,
in an area rostral to where FGF8 is expressed (Wilkinson et al., 1987).
Interestingly, FGF8 signalling has also been shown to regulate En1
expression in the developing VM (Lahti et al., 2012). It is tempting to
speculate that this may be achieved through the induction of Wnt1.
In support of this suggestion, a functional link between FGF8 and
Wnt signalling has recently been described, where it was shown that
Wnt-β-catenin signalling positively regulated FGF8 expression in the
midbrain-rhombomere1 region (Chilov et al., 2010). It is possible that
this may be an autoregulatory loop, similar to that of Shh and FoxA2,
with FGF 8 inducing the expression of Wnt1 and subsequently En1/
En2 expression in the midbrain. Interestingly, new data have now
shown that Lmx1a and Lmx1b function cooperatively to control the
proliferation of VM DA NPs through the regulation of Wnt1 expres-
sion (Yan et al., 2011).A link between Shh and Wnt signalling has recently emerged
with the proposal that canonical Wnt-β-catenin signalling is
required to antagonise Shh, and that the subsequent reduced Shh
levels allow the induction of VM DA NPs and the promotion of DA
neurogenesis (Joksimovic et al., 2009b). The ﬁnding that Shh
inhibits DA neurogenesis (Joksimovic et al., 2009b) is surprising,
considering its well-established role in the induction of VM DA
neurogenesis (Andersson et al., 2006; Blaess et al., 2006; Hynes
et al., 1995a; Ye et al., 1998). However, Joksimovic et al., 2009a,
2009bsuggest that Shh is initially required for the early establish-
ment of the VM DA NP pool, but that later it inhibits VM DA NP
proliferation and neurogenesis. The current model suggests that
once the Shh-induced VM DA NP pool has been established, Wnt-
β-catenin signalling suppresses Shh levels in the VM to facilitate
DA neurogenesis. Additionally Wnt signalling has been shown to
induce Otx2 and Lmx1a expression (Joksimovic et al., 2009b;
Prakash et al., 2006). Furthermore, a Wnt1–Lmx1a autoregulatory
loop has been identiﬁed which is proposed to regulate Otx2
expression via β-catenin during VM DA neurogenesis (Chung
et al., 2009). Interestingly, Otx2 has recently been suggested to
regulate the proliferation of VM DA NPs via Wnt1 regulation
(Omodei et al., 2008), suggesting a possible Otx2-Wnt1 regulatory
feedback loop. In contrast to Joksimovic et al. (2009); Chung et al.
(2009) suggested a mechanism by which the Wnt1–Lmx1a auto-
regulatory loop and a Shh–FoxA2 autoregulatory loop control VM
DA neurogenesis synergistically. Despite this ﬁnding, a more
recent paper described an antagonistic relationship between
Wnt-β-catenin signalling and Shh signalling that is important in
the progression of DA NPs into VM DA neurons (Tang et al., 2010),
thus supporting the Joksimovic et al. (2009) theory. Furthermore,
the stabilisation of β-catenin in VM NPs, by the inhibition of
GSK3β, leads to an increase in DA differentiation (Castelo-Branco
et al., 2004; Tang et al., 2009) and targeted deletion of β-catenin in
VM NPs (Th-IRES-Cre; β-CtnEx3/+ mutant) results in reduced VM
DA neurogenesis (Tang et al., 2009). Surprisingly, mice with
mutations in the Wnt/β-catenin inhibitor Dkk1 actually have a
reduction in VM DA neurons (Ribeiro et al., 2011). This is surpris-
ing, given that the stabilisation of β-catenin in VM NPs, through
the inhibition of GSK3β, leads to an increase in DA differentiation
(Castelo-Branco et al., 2004; Tang et al., 2009). Collectively these
data largely support the theory that Wnt signalling is required for
DA induction, but it is also clear that this is likely to involve a
complex interplay with Shh and FGF8 signalling, and potentially
other extrinsic signalling factors which have been suggested to
induce VM DA neurogenesis, including TGFβs (Farkas et al., 2003;
Roussa et al., 2009, 2006).Development of post-mitotic ventral midbrain
dopaminergic neurons
Once NPs of the VM ﬂoor plate are speciﬁed towards a DA
phenotype, these DA NPs gradually become post-mitotic from E10-
E14 in mice (E12–E16 in rats) (Lauder and Bloom, 1974; Lumsden and
Krumlauf, 1996), with the greatest proportion of VM DA NPs under-
going their ﬁnal division at E12 in the rat (Gates et al., 2006). The
induction of TH expression, the rate-limiting enzyme for DA synth-
esis, is the ﬁrst sign of the acquisition of the DA neuronal phenotype,
and occurs shortly after the ﬁnal mitosis of VM DA NPs while they
are actively migrating to their ﬁnal positions (Puelles and Verney,
1998, Specht et al., 1981a; Specht et al., 1981b). This process of
migration of VM DA neurons from the ﬂoor plate ventricular zone to
the presumptive VTA and SNc involves two steps: ﬁrstly, DA neurons
migrate ventrally along tenascin-expressing radial glial processes
which project to the pial surface, and secondly, once they have
reached the basal part of the VM, they migrate laterally along
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1995; Shults et al., 1990). These tangentially-orientated ﬁbres express
the neural cell adhesion molecule L1, while VM DA neurons express
the chondroitin sulphate proteoglycan 6B4. A heterophilic interaction
between L1 and 6B4 has been proposed to facilitate this process of
lateral migration of VMDA neurons (Ohyama et al., 1998). There have
been a variety of studies that show that this process of migration is
crucial for the normal positioning of VM DA neurons. Speciﬁcally, VM
DA neurons are abnormally located in L1 knockout mice
(Demyanenko et al., 2001). A role for Wnt signalling in this process
has been implicated by a study showing that the targeted deletion of
β-catenin in the VM disrupts the integrity of these radial glia,
resulting in perturbed migration of VM DA neurons (Tang et al.,
2009). It is unclear whether these migratory defects are secondary to
a disrupted radial glial scaffold or whether Wnt signalling can also
directly affect this process of migration. A number of other molecules
involved in neuronal migration in the developing CNS also appear to
be involved in the migration of VM DA neurons. These include the
well-known migrational regulator Reelin, as VM DA neurons fail to
migrate laterally to the SNc, in reeler (reelin null) mice (Nishikawa
et al., 2003), and the netrin receptor, DCC, which is expressed by
migrating VM DA neurons in mice, and its loss results in aberrant
migration of these neurons (Xu et al., 2010). In terms of the molecular
regulatory networks that control this migration, there have been a
number of studies describing roles for Ebf1 (early B-cell factor 1) (Yin
et al., 2009) and Hes1 (Kameda et al., 2011) in this process. A key goal
for future research will be to understand the molecular networks
that control this process of VM DA migration and how newly-
identiﬁed molecules such as Ebf1 and Hes1 “ﬁt” within this network.
While much work has focused on identifying the molecular signals
that are required for neuronal migration, it will also be important to
understand what positional cues inhibit these processes so that VM
DA neurons “know” when to stop.
Several transcription factors have been identiﬁed which are
essential for the differentiation and subsequent long-term survival
of VM DA neurons. These include Lmx1b, Nurr1, Pitx3, En1 and
En2. Each of these factors are not individually capable of inducing
a complete DA phenotype, suggesting that they function as part of
a network (Fig. 1).
Lmx1b
The lim-homeodomain factor Lmx1b is broadly expressed in the
presumptive midbrain before neural tube closure, and its expres-
sion becomes restricted to VM DA NPs at E10.5 in mice, where it is
co-expressed with Lmx1a and Msx1 (Andersson et al., 2006; Smidt
et al., 2000). Surprisingly, Lmx1b expression disappears in the VM
at around E11.5, but reappears at E16 in post-mitotic VM DA
neurons. Lmx1b is subsequently co-expressed with Pitx3 and TH
into adulthood in the VM (Dai et al., 2008). Although loss of Lmx1b
leads to a loss of VM DA neurons (Smidt et al., 2000), Lmx1b
mutant mice express Nurr1 and TH normally during early devel-
opment, but fail to express Pitx3. These TH-positive VM neurons,
which lack Pitx3 expression, are lost by birth, suggesting a role for
Lmx1b in the regulation of Pitx3 expression and VM DA neuronal
survival. Similarly in Wnt1 null mice, the few TH-positive VM
neurons generated lack Pitx3 expression, and are subsequently lost
before E12.5 (Prakash et al., 2006). A similar regulatory loop may
exist between Wnt1 and Lmx1b, as Lmx1b induces and/or main-
tains the expression of Wnt1, an important extrinsic factor in VM
DA neurogenesis (see above), around the midbrain-hindbrain
boundary (Adams et al., 2000; Matsunaga et al., 2002). Wnt1 has
also been proposed to act downstream of Lmx1b in the potential
regulation of Pitx3 expression (Prakash et al., 2006). This main-
tenance of Wnt1 expression by Lmx1b may be important in the
generation of post-mitotic DA neurons, as Wnt1 is required for theterminal differentiation of VM DA neurons at later stages of
embryogenesis (Prakash et al., 2006).
Nurr1
Nurr1 is a member of the nuclear receptor superfamily of
steroid-thyroid hormone-activated transcription factors (Law
et al., 1992), which atypically lacks both a ligand cavity and a
canonical coactivator-binding site (Wang et al., 2003). Nurr1 is
expressed in the VM from E10.5 in the mouse, as VM DA NPs begin
to become post-mitotic, one day before the appearance of TH
(Zetterstrom et al., 1996), and Nurr1 expression is maintained into
adulthood (Backman et al., 1999). Nurr1 expression levels show a
sharp peak between E13 and E15 in the rat, at a stage of
development when most VM DA neurons are undergoing terminal
differentiation (Volpicelli et al., 2004). VM DA neurons in Nurr1-
deﬁcient animals do not express TH, l-aromatic amino acid
decarboxylase (AADC), the vesicle monoamine transporter 2
(VMAT2) or the dopamine transporter (DAT), all markers of a DA
neuron that has acquired its DA neurotransmitter identity (Castillo
et al., 1998; Filippi et al., 2007; Smits et al., 2003). Nurr1 has been
shown to play a direct role in regulating the expression of these
genes, and a number of well-established signalling pathways in
VM DA development cooperate with Nurr1 to mediate this induc-
tion. Speciﬁcally, Nurr1 has been shown to induce TH expression
by binding to a NRBE (NGFI-B response element) sequence in the
TH promoter (Kim et al., 2003; Sakurada et al., 1999), and is known
to induce DAT expression via an NRBE-independent mechanism
(Sacchetti et al., 2001). These effects of Nurr1 on the expression of
these genes are enhanced by Wnt-activated β-catenin, which has
been shown to promote Nurr1-induced TH promoter activation, by
interacting with Nurr1 at NRBEs, causing the dissociation of
transcriptional co-repressors and recruitment of transcriptional
co-activators (Kitagawa et al., 2007). Similarly, nuclear FGFR1 has
been shown to cooperate with Nurr1 to promote activation of the
TH promoter (Baron et al., 2012a). Collectively these data show
that Nurr1 functions as a master regulator in the induction of the
neurotransmitter phenotypic identity of VM DA neurons, and
controls the expression of the molecules that regulate the synth-
esis, vesicle packaging, axonal transport and reuptake of DA.
Aside from this role in DA identity, Nurr1 has also been shown
to be crucial for long-term VM DA neuron survival. In Nurr1-
deﬁcient animals, VM DA neurons adopt a correct ventral position
and express the DA markers Lmx1b, Pitx3 and En1 (Saucedo-
Cardenas et al., 1998; Wallen et al., 1999), demonstrating that
Nurr1 is not required for all aspects of VM DA speciﬁcation and
differentiation. However, these Pitx3-expressing VM DA neurons
are lost in Nurr1-deﬁcient animals during later development
(Saucedo-Cardenas et al., 1998), suggesting a role for Nurr1 in
the survival and maintenance of VM DA neurons. In support of
these ﬁndings, Nurr1 is expressed throughout the life of VM DA
neurons and its heterozygous mutation increases the vulnerability
of VM DA neurons to the parkinsonian toxin, 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine-HCl (MPTP) (Le et al., 1999). Further-
more, the conditional ablation of Nurr1 at a late stage of VM DA
neuron development or in the adult brain results in loss of striatal
DA, loss of VM DA markers and DA neurodegeneration, with SNc
DA neurons more vulnerable than those of the VTA (Kadkhodaei
et al., 2009).
While Nurr1 has been shown to directly regulate the expres-
sion of TH and DAT, Nurr1 may promote VM DA neuron survival
indirectly, by inducing the expression of genes essential for their
survival. Nurr1 has been found to regulate the expression of the
glial cell line-derived neurotrophic factor (GDNF) receptor, cRet,
whose expression is lost in Nurr1-deﬁcient animals (Castillo et al.,
1998). GDNF is a well-known survival-promoting factor for VM DA
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et al., 2007). Nurr1 has also been shown to regulate the expression
of VIP (vasoactive intestinal peptide), which has been proposed to
function in the survival of VM DA neurons (Luo et al., 2007). It
remains to be determined whether the VM DA neuronal death in
Nurr1 null mutants is as a direct consequence of the absence of a
Nurr1-mediated survival-promoting effect, and/or is induced
by a lack of neurotransmission by these cells. Aside from its role
in DA survival, Nurr1 has been suggested to play a role in target
innervation by VM DA neurons (Wallen et al., 1999); however, this
ﬁnding has been challenged (Witta et al., 2000). It will be
important to assess the role of Nurr1 in striatal innervation
in vivo using an approach where DA neurons can survive long
term in the absence of Nurr1. Such a strategy has been employed
successfully in the PNS, where Bax-deﬁcient mice were used to
analyse speciﬁcally the effects on a gene of interest on target
innervation independent of this genes role in neuronal survival
(Barker et al., 2001; Glebova and Ginty, 2004; Middleton and
Davies, 2001).
The molecular mechanisms by which Nurr1 expression is
induced and regulated in the VM are largely unknown, but Nurr1
has been shown to function independently of FGF8 and Shh
signalling (Sakurada et al., 1999). However, recent data suggests
that FoxA1 and FoxA2 may be critical to Nurr1 induction. Through
the analysis of single and double mutants, FoxA1 and FoxA2 have
been reported to regulate the expression of Nurr1 in a dose-
dependent manner, with a dramatic decrease in Nurr1 expression
observed in double mutants (Ferri et al., 2007). In addition to this,
a gain-of-function study has demonstrated that FoxA2 mediates
Nurr1 expression (Lee et al., 2010). Lee et al. (2010) further
demonstrated that FoxA2 acts synergistically cooperates with
Nurr1 during VM DA neurogenesis, with both factors binding to
the TH promoter. In support of this, the loss of FoxA2 resulted in an
increase in the numbers of Nurr1-positive, TH-negative, cells in
the VM (Ferri et al., 2007). These more recent data suggest that
Nurr1 function may not be independent of Shh signalling, as FoxA2
is a downstream target of Shh; however FoxA2 can function
independently of Shh. Similar to Nurr1, FoxA2 appears to be
involved in the survival and maintenance of VM DA neurons, as
aged mice with a heterozygous mutation in FoxA2 develop PD-like
symptoms and pathologies (Kittappa et al., 2007), but this maybe
due to altered FoxA2-induction of Nurr1 expression.
Pitx3
Pitx3 is a bicoid-related, homeodomain-containing transcrip-
tion factor that is exclusively expressed in the mouse VM from
E11.5, at a time when VM DA neurons are beginning to appear
(Smidt et al., 1997). VM DA neurons only begin to express Pitx3
when they arrive at their ﬁnal ventral position, suggesting that
Pitx3 is not involved in the early development or migration of VM
DA neurons (Smidt et al., 2004). GDNF has been suggested to
induce the expression of Pitx3 in the VM (Lei et al., 2011; Peng
et al., 2011) which is interesting as Nurr1 is known to regulate the
expression of the GDNF receptor cRet, and is expressed before Pitx3
in the VM. Nurr1 may therefore play an indirect, non-essential
(Pitx3 expression is retained in Nurr1 null mutants) role in the
induction of Pitx3 expression. Pitx3 and Nurr1 have been shown to
function cooperatively in the regulation of target genes involved in
VM DA neurogenesis (discussed later) (Chakrabarty et al., 2012;
Hwang et al., 2009; Jacobs et al., 2009a; Jacobs et al., 2009b). Pitx3
is co-expressed in the TH-positive neurons of the VM (Smidt et al.,
1997; Van Den Munckhof et al., 2003; Zhao et al., 2004). In aphakia
mice, which lack Pitx3 expression due to deletions in the Pitx3
gene, there is unaltered VM DA development until E12.5, at which
time a deﬁcit is observable in the lateral population of VM DAneurons which constitute the presumptive SNc (Hwang et al.,
2003; Nunes et al., 2003; Smidt et al., 2004; Van Den Munckhof
et al., 2003). VTA DA neurons are largely unaffected in these mice.
The speciﬁc absence of SNc DA neurons in Pitx3 null (aphakia)
mice results in a loss of nigrostriatal projections to the dorsal
striatum (Hwang et al., 2003; Nunes et al., 2003; Smidt et al.,
2004; Van Den Munckhof et al., 2003), and suggests distinct
developmental programmes for SNc and VTA DA neurons. Inter-
estingly, it has been reported that lateral VM DA neurons express
Pitx3 prior to TH, while the medial VM DA neurons express Pitx3
coincidently with TH (Maxwell et al., 2005). In addition to this,
Pitx3 has been suggested to regulate TH expression (Cazorla et al.,
2000; Lebel et al., 2001; Maxwell et al., 2005). Pitx3 may therefore
be critical for the induction of TH expression in SNc DA neurons,
but not those of the VTA. In support of this, the absence of Pitx3
results in a failure of SNc DA neurons to express TH, while VTA
neurons do so. Interestingly, Pitx3 expression has been reported to
be six times higher in VTA DA neurons then in those of the SNc
(Korotkova et al., 2005). Perhaps this lower expression level of
Pitx3 functions in the induction of TH expression in SNc DA
neurons, while it may also contribute to their inherent sensitivity.
In support of the proposed role for Pitx3 in TH expression, Pitx3
has been shown to contribute to the neurotransmitter phenotype
of VM DA neurons by inducing the expression of DAT and VMAT2
(Hwang et al., 2009). However, the loss of TH-positive neurons in
the ventro-lateral VM is not due to the loss of TH mRNA expres-
sion, but to neuronal loss (Hwang et al., 2003; Nunes et al.,
2003; Smidt et al., 2004). Perhaps the selective neurodegeneration
of SNc DA neurons in aphakia mice is not as a result of a failure of
DA neurogenesis in the absence of Pitx3, but may reﬂect the
characteristic sensitivity of this VM population in comparison to
those of the VTA. Indeed, the VTA DA neurons in aphakia mice
display a normal DA phenotype (Smidt et al., 2004). A recent study
has demonstrated that Pitx3 induces the expression of brain-
derived neurotrophic factor (BDNF) in SNc DA neurons, which may
be important in the survival of these neurons (Peng et al., 2011).
Peng et al. (2011) showed that loss of BDNF expression correlates
with the SNc neuronal loss in Pitx3 null mice, and that BDNF
treatment induces the survival of Pitx3 (−/−) VM DA neurons and
protects them against the dopaminergic neurotoxin 6-
hydroxydopamine. Pitx3 may therefore be critical in the main-
tenance and survival of SNc DA neurons, acting via BDNF. Similarly,
BDNF has been identiﬁed as a target gene of Nurr1 (Volpicelli et al.,
2007).
Despite the lack of a direct role for Nurr1 in Pitx3 expression, a
recent set of studies has shown that Nurr1 regulates target gene
expression cooperatively with Pitx3 during VM DA neurogenesis,
with Pitx3 potentiating Nurr1 activity by releasing it from SMRT-
mediated repression (Jacobs et al., 2009a, 2009b). Similarly, the
same group demonstrated that Nurr1 and Pitx3 cooperatively
regulate the expression of two cholinergic receptors, Chrna3 and
Chrnb6, which may play non-essential roles in VM DA neurogen-
esis (Chakrabarty et al., 2012). Furthermore, Pitx3 has been shown
to induce the expression of the Nurr1-target genes, VMAT2 and
DAT, potentially in coordination with Nurr1 (Hwang et al., 2009),
with Pitx3 also inducing the expression of aldehyde dehydrogen-
ase 2 (ADH2), an enzyme which is highly expressed in SNc DA
neurons (Chung et al., 2005). In support of this combinatorial
function, Nurr1 and Pitx3 have been shown to cooperatively
promote terminal maturation of VM DA neurons in stem cell
cultures (Martinat et al., 2006) Collectively, these data suggest
Nurr1 and Pitx3 may cooperate to promote VM DA survival and
acquisition of a mature DA neurotransmitter phenotype by coop-
eratively regulating the expression of DA neurotrophic factors,
BDNF and GDNF, and of genes involved in DA neurotransmission
respectively.
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En1 and En2 are important in the formation of the isthmus
organiser and in the generation of VM DA neurons (Liu and Joyner,
2001; Simon et al., 2001). Following their initial expression in the
midbrain-hindbrain boundary (Davis and Joyner, 1988), VM DA
neurons begin to express En1 and En2 between E11.5 and E14 in
mice, and this expression is maintained into and throughout
adulthood (Alberi et al., 2004). Interestingly, in En1 and En2 double
mutants, VM DA neurons develop normally initially, but are lost by
E14 due to caspase-dependent apoptosis, just after the expression
of En begins in the wild type (Alberi et al., 2004; Simon et al.,
2001). Alberi et al. (2004) demonstrated that En1 and En2 are
required cell-autonomously in post-mitotic VM DA neurons to
prevent apoptosis. However, further studies are required to ascer-
tain that VM DA neuronal loss in the En double mutants is not as a
result of the large midbrain/hindbrain deletion in these mice.
Despite this possibility, these data strongly suggest a role for En1
and En2 in the maintenance and survival of VM DA neurons.
Indeed, intermediate genotypes between wild type and double En
mutants show varying degrees of VM DA neuronal deﬁciencies
(Sgado et al., 2006; Simon et al., 2001; Sonnier et al., 2007), as has
been well-described in recent reviews (Alavian et al., 2008; Alves
Dos Santos and Smidt, 2011). The most notable phenotype was
observed in En1 (+/−)/En2 (+/+) mutant mice, which display a
progressive degeneration (between 8 and 24 weeks) of VM DA
neurons that can be antagonised by recombinant En2 protein
infusion (Sonnier et al., 2007). The progressive degeneration of VM
DA neurons in En1 heterozygotes (En2 null background in Sgado
et al. (2006) study) is more pronounced in the SNc and results in
reduced striatal DA and motor deﬁcits, as is characteristic of PD
pathology (Sgado et al., 2006; Sonnier et al., 2007). These ﬁndings
further support the theory that En1/En2 function as important
survival-promoting factors for VM DA neurons.
Diversity in genetic regulation of DA neuron development
As mentioned earlier, the molecular mechanisms controlling
phenotypic and functional diversity between the various VM DA
neuronal subpopulations remain poorly understood. However,
recent work has implicated Otx2 as a factor that may contribute
to these distinct developmental pathways. FoxA2, En1, Lmx1b,
Nurr1 and Pitx3 are ubiquitously expressed in post-mitotic VM
DA neurons throughout life; however Otx2 expression is restricted
to VTA DA neurons in the adult brain (Di Salvio et al., 2010b). Otx2
was shown to regulate subtype identity in the VTA by antagonising
the expression of Girk2 and DAT, and was also shown to antagonise
the neurotoxic effect of the MPTP in these VTA neurons (Di Salvio
et al., 2010a). Interestingly, ectopic Otx2 expression also provides
SNc neurons with neuroprotection to MPTP (Di Salvio et al.,
2010a). This potential role of Otx2 in VM DA neuronal subtype
identity has been comprehensively described in a recent review
(Simeone et al., 2011).
It is also necessary to mention that a proportion of DA neurons
arise anterior to the VM in the diencephalon (Gonzalez et al., 1999.
Lahti et al., 2012; Marin et al., 2005; Puelles and Verney, 1998;
Smits et al., 2006; Verney, 1999; Verney et al., 2001. Vitalis et al.,
2000), and develop earlier than those from the VM (Lahti et al.,
2012; Marin et al., 2005). The diencephalic DA domain differs to
that of the midbrain. The DA NPs in the diencephalon are
intermingled with non-DA Pou4f1+FoxP1+ cells, they lack Pitx3
and DAT expression, and lose En1/2 expression by E9.5 (Lahti et al.,
2012), unlike those in the midbrain (Alberi et al., 2004). FGF8
regulates the diverse identities of the DA neurons from the VM
and caudal diencephalon. This anterior–posterior patterning by
FGF8 suppresses diencephalic identity and maintains midbrainidentity (Lahti et al., 2012; Scholpp et al., 2003). A study using
zebraﬁsh showed that Nodal signalling was required for the
speciﬁcation of ventral diencephalic and pretectal catecholami-
nergic neurons (Holzschuh et al., 2003). (Holzschuh et al., 2003)
also demonstrated that FGF8 signalling was not required for the
speciﬁcation of these neurons but was important for their pro-
liferation or survival, and that Shh signalling is required for
pretectal DA development. Diencephalic DA neurons therefore
seem to be subject to a different programme of neurogenesis than
those of the VM. Genetic fate-mapping studies are needed to verify
whether, or to what extent, these diencephalic DA neurons
contribute to the DA subpopulations of the VM.Establishment of dopaminergic projections from the ventral
midbrain
Following their generation, post-mitotic VM DA neurons
undergo functional maturation, which involves axonal pathﬁnding
and synaptogenesis. Axons from VM DA neurons, which arise at
E11 in mice (E13 in rat), initially project dorsally but then deﬂect
ventro-rostrally towards the forebrain, in response to extrinsic
directional cues in the dorsal midbrain and repulsive cues in the
caudal brain stem (Gates et al., 2004; Nakamura et al., 2000). The
reorientated VM DA neuronal axons then extend towards the
telencephalon, through the diencephalon, via the medial forebrain
bundle (MFB) which has been reported to have a chemo-attractive
effect on these axons (Gates et al., 2004). A recent paper has
suggested that Nurr1 regulates the axonal extension of VM DA
neurons through the regulation of the expression of the axon
genesis gene Topoisomerase IIβ (TopIIβ) (Heng et al., 2012). Further-
more, a study using retrograde labelling suggested that Nurr1
plays a role in target innervation by VM DA neurons (Wallen et al.,
1999). However, as mentioned before, this ﬁnding has been
challenged (Witta et al., 2000). Gates et al. (2004) also demon-
strated that the thalamus prevents entry of VM DA axons through
the action of contact-dependent inhibitors, which likely function
to maintain the orientation of these axons in the MFB. Further-
more, Nkx2.1 mutant mice display aberrant midline crossing of
MFB ﬁbres at the caudal diencephalon, suggesting that chemo-
repulsive factors involved in maintaining the ipsilateral trajectory
of the MFB at the medial part of the caudal diencephalon are lost
in this mutant (Kawano et al., 2003).
The VM DA neuronal axons run via the MFB into the tele-
ncephalon, where they terminate in the striatum and cerebral
cortex (Specht et al., 1981a, 1981b; Zhao et al., 2004). In the case of
the nigrostriatal pathway, chemoattraction from the striatum and
chemorepulsion from the cortex have been suggested to facilitate
appropriate striatal innervation by nigral DA neurons (Gates et al.,
2004). The molecular signals that guide the axons of the various
populations of VM DA neurons remain to be characterised;
however a relatively recent review has comprehensively described
the current understanding of the development of VM DA circuitry
(Van Den Heuvel, Pasterkamp, 2008). Molecules which are known
to be involved in the establishment of the VM DA circuit are
illustrated in Fig. 2.
Despite the current paucity of studies determining the mole-
cular basis of the formation of VM DA projections, several
molecules have been implicated to play a role in this process.
EphrinB2 and its receptor EphB1 have been shown to be expressed
in a complementary pattern to facilitate nigro-striatal innervation,
with EphB1 expressed by VM DA neurons (with highest expression
in the SNc) and ephrinB2 expressed in the striatum (Yue et al.,
1999). Cell-surface tethered ephrins, and their Eph receptor
tyrosine kinases, are known to play important roles in axonal
guidance (Egea and Klein, 2007). Furthermore, Yue et al. (1999)
Fig. 2. Molecules involved in the formation of the nigrostriatal DA circuitry. Development of the rat nigrostriatal pathway: Representative photomicrographs showing
cryosections through the developing rat nigrostriatal pathway at (A) E14, (B) E16 and (C) E18, immunostained for TH. Molecules involved in the migration (A), axon extension
(B), axon orientation (B), target innervation (C) and survival (C) of VM DA neurons are labelled on the images where appropriate. Scale bar¼100 μm. (D) Graphical
representation of the time-course of DA circuitry formation. VM DA neurons begin to migrate and extend axons at E13 in the rat. These DA ﬁbres begin to reach the striatum
by E14, and the cortex at E16. The innervation of these targets continues into the ﬁrst week after birth. Naturally occurring cell death begins close to birth, reaching a peak at
P2 and P14, before subsiding around P20.
S.V. Hegarty et al. / Developmental Biology 379 (2013) 123–138132showed that co-culture with ephrinB2-expressing NIH-3T3 cells
reduced neurite outgrowth and induced death of SNc, but not VTA,
DA neurons. These results suggest that the interaction between
ephrinB2 and EphB1 in the striatum ensures that SNc DA neurons
are conﬁned to the dorsal striatum. Conversely, EphB1 expression
has been shown to disappear in the SNc from E18, and its null
mutation resulted in no observable defects in the nigrostriatal
pathway (Richards et al., 2007). These results challenge the role for
EphB1 in the formation of the nigrostriatal pathway; however
other Eph receptors may allow SNc DA axons to detect ephrinB2 in
the striatum. In support of a role for ephrinB2 in the correct target
innervation of nigral DA neurons, the application of ephrinB2 to
VM cultures resulted in an upregulation of Nurr1 (Calo et al.,
2005). This action by ephrinB2 could function to support and
maintain correctly-innervated DA neurons. However, this effect
was suggested to be mediated by the EphB1 receptor (Calo et al.,
2005). Other ephrins and Ephs have also been implicated in DA
pathway formation. For example, studies on genetically-altered
EphAs and ephrinAs have shown that these molecules are impor-
tant in the formation of VM DA projections (Halladay et al., 2004;
Sieber et al., 2004; Van Den Heuvel, Pasterkamp, 2008), with
ephrinA5 expression being reduced in the forebrain of Nkx2.1
mutants (described above) (Marin et al., 2002). EphrinA5 has been
shown to be expressed in the developing telencephalon and
striatum, in the vicinity of VM DA axons, and to have a repulsive
effect on these axons, likely through the action of EphA5
(Deschamps et al., 2009). Conversely, another study has shown
that ephrinA5-EphA5 signalling promotes DA axonal growth
in vitro (Cooper et al., 2009). Perhaps ephrinA5 initially functions
in the establishment of VM DA projections, but later functions to
restrict these axons to their targets. Semaphorin signalling has also
been proposed to function in VM DA axonal pathﬁnding
(Hernandez-Montiel et al., 2008; Kolk et al., 2009, Tamariz et al.,
2010; Torre et al., 2010), with a number of semaphorins and their
receptors being expressed in VM DA neurons (Torre et al., 2010).Furthermore, Sema3A expression is reduced in Nkx2.1 mutants
(Kawano et al., 2003), and the expression of its co-receptor
Neuropilin1 has been shown to be regulated by Nurr1 in the
developing midbrain (Hermanson et al., 2006).
The netrin receptor DCC has been demonstrated to play an
important role in the formation of VM DA axonal projections. DCC
is expressed in the VM and in cultured VM DA neurons, as well as
in VM DA targets, such as the striatum and prefrontal cortex (Lin
et al., 2005; Livesey and Hunt, 1997; Xu et al., 2010), while netrin1
is expressed in a complimentary fashion in VM, striatal and
cortical neurons (Hamasaki et al., 2001; Livesey and Hunt, 1997;
Manitt et al., 2011). Studies of heterozygous and homozygous DCC
mutants have provided insights into how netrin-DCC signalling
may regulate the formation of VM DA neuronal projections (Flores
et al., 2005; Xu et al., 2010). DA innervation of the dorsal striatum
is not affected in heterozygous and homozygous DCC mutants,
while the ventral striatal DA projections are aberrantly shifted to a
more dorsal location in null mutants. The innervation of the
prefrontal cortex by VM DA neurons is signiﬁcantly reduced in
null mutants, suggesting that DCC is an important mediator of VM
DA axonal guidance. Xu et al. (2010) also propose that DCC
signalling is an important negative regulator of DA axon arborisa-
tion, demonstrating that DA innervation is maintained/increased
despite signiﬁcant VM DA neuronal loss in DCC deﬁcient animals.
In support of this, analysis of heterozygous DCC mutants has
shown that DCC can selectively inﬂuence the branching of VM
DA ﬁbres in the prefrontal cortex at puberty, with a signiﬁcant
increase in the number of TH-positive varicosities present post-
puberty in these heterozygotes (Manitt et al., 2011). This proposed
role of DCC contradicts previous reports which had suggested that
DCC mediates netrin1-promotion of axonal outgrowth in VM DA
neuronal cultures (Lin et al., 2005). However, these contrasting
results may reﬂect differences between the responses of VM DA
neurons in vitro and in vivo. Furthermore, DCC receptors are
known to mediate both attraction and repulsion aspects of the
S.V. Hegarty et al. / Developmental Biology 379 (2013) 123–138 133axon growth-promoting effects of netrins (Round and Stein, 2007).
The atypical homeoprotein Pbx1a has been shown to regulate the
expression of DCC in VM DA neurons, and its deﬁciency results in
partial misrouting of VM DA ﬁbres (Sgado et al., 2012). Interest-
ingly, DCC null mice also display aberrant midline crossing of MFB
DA ﬁbres at the caudal diencephalon, which is similar to that
observed in Nkx2.1mutant mice (Xu et al., 2010), likely reﬂecting a
loss of chemorepellant(s) at the ventral midline. In Pax6 null mice,
which display a ventro-dorsal expansion of netrin1 expression, VM
DA axons within the MFB are deﬂected dorsally in the diencepha-
lon, seemingly avoiding areas of ectopic netrin1 expression (Vitalis
et al., 2000). Netrin-DCC signalling may therefore act at the ventral
midline of the diencephalon to repel VM DA projections, ensuring
that they maintain their ipsilateral course in the MFB. Similarly,
mice deﬁcient in both Slit1 and Slit2 display abnormal ventral
midline crossing of MFB ﬁbres in the diencephalon, suggesting
they may also act as ventral midline chemorepellants (Bagri et al.,
2002; Dugan et al., 2011). In support of this theory, Slit2 repels VM
DA neuronal axons and inhibits their growth in vitro (Dugan et al.,
2011; Lin et al., 2005). Nkx2.1mutant mice display altered Slit1 and
Slit2 expression, and a more severe phenotype than that of Slit1/
Slit2 double mutants (Marin et al., 2002). This suggests that Nkx2.1
may regulate the expression of a number of important chemor-
epellants at the diencephalic ventral midline, such as Slit1/Slit2,
Sema3A, ephrinA5 and perhaps netrin1. However, netrin1 expres-
sion is maintained in the subpallium of the Nkx2.1 mutants (Marin
et al., 2002), and has been reported to attract diencephalic (A11)
DA neurons towards the ventral midline in the absence of
repulsive Slit signals (Kastenhuber et al., 2009). Mice deﬁcient in
the Slit receptors, Robo1 and Robo2, also display guidance errors in
the MFB tract similar to those in the Slit double mutant (Dugan
et al., 2011; Lopez-Bendito et al., 2007). However, Dugan et al.
(2011) also demonstrated abnormal dorsal trajectories of VM DA
ﬁbres in Robo1/2 knockout mice, which does not occur in the Slit1/
2 mutant, suggesting that these Robos also function Slit-
independently. The expression patterns of Slits also propose a role
for these molecules in VM DA axonal guidance, with Slit1
expressed in the dorsal midbrain (Nakamura et al., 2000) and Slit3
expressed in the caudal midbrain (Gates et al., 2004), suggesting
that these Slits contribute to the ventro-rostral trajectory of VM DA
ﬁbres.
Upon innervation of their targets, the axons of VM DA neurons
compete to establish functional synapses and survive. There are
two peak postnatal periods of naturally-occurring cell death for
VM DA neurons. Cell death begins close to birth, reaching an initial
peak at P2, before a second peak of apoptosis occurs at P14, with
this process largely subsiding around P20 in rodents (Burke, 2003;
Jackson-Lewis et al., 2000; Oo and Burke, 1997). This programmed
cell death pathway relies on the limited availability of target-
derived neurotrophic factors (Burke, 2003), with striatal and
prefrontal cortex tissue being shown to promote VM DA neuronal
survival when co-cultured in vitro (Hoffmann et al., 1983). The
most well-established target-derived neurotrophic factor for VM
DA neurons is GDNF (Akerud et al., 1999; Beck et al., 1995; Burke,
2003; Costantini and Isacson, 2000; Gash et al., 1996; Lei et al.,
2011; Lin et al., 1993; Redmond et al., 2009; Tomac et al., 1995;
Wang et al., 2010). Another member of the GDNF protein
family, neurturin (NTN), also acts as a neurotrophic factor for VM
DA neurons (Akerud et al., 1999; Horger et al., 1998; Oiwa et al.,
2002; Tseng et al., 1998; Zihlmann et al., 2005). Other neuro-
trophic factors identiﬁed for VM DA neurons include transforming
growth factor βs (TGFβs) (Farkas et al., 2003), BDNF (Alonso-
Vanegas et al., 1999) and growth/differentiation factor 5 (GDF5)
(Costello et al., 2012; Hurley et al., 2004; O'Keeffe et al., 2004;
O'Sullivan et al., 2010; Sullivan and O'keeffe 2005; Sullivan et al.,
1997, 1998). Interestingly, FGF2 has recently been shown to act asa target-derived regulator of VM DA innervation (Baron et al.,
2012b).Concluding remarks and future perspectives
This paper reviews the recent data from molecular studies on
VM DA development, and highlights a number of important
genetic pathways involved during the neurogenesis of these cells.
It is clear that this is a complex developmental programme,
complicated further by the fact that VM DA neurons are not a
homogenous population of neurons. However, insights are begin-
ning to be made on the molecular mechanisms that may, in part,
confer subtype identity within the VM DA circuit, such as those
described for Shh, Pitx3 and Otx2. Despite these developments,
future studies will be crucial to elucidate the molecular basis of
these subtle developmental differences between A8, A9 and A10
DA neuronal identities.
VM DA neurons are now known to arise from ﬂoor plate radial
glial-like NPs in response to speciﬁcation by FGF8, Shh and Wnt1.
This recent discovery is important if VM DA NPs are to be
speciﬁcally isolated for use in cell replacement therapies. Addi-
tionally, Wnt1 is now accepted as an extrinsic factor for VM DA
neurons, along with Shh and FGF8, which has added another
dimension to the developmental programme of VM DA neurogen-
esis. A number of TGFβ superfamily members, and other Wnts,
have also been implicated as instructive signalling molecules
during VM DA neurogenesis. Similar to the recent studies carried
out for Wnt1, these candidates should be investigated thoroughly
for their participation in these developmental processes.
The discovery of a number of new candidate transcription
factors, for example Oc1/2/3, highlights that there are likely to
be other, as yet unidentiﬁed, molecular pathways involved in
regulating VM DA neurogenesis. Furthermore, new relationships
are being uncovered between the transcription factors and mole-
cular pathways that are well-known to play key roles in DA
development. For example, Nurr1 and Pitx3 were previously
thought to function independently, however, recent data show
that these key transcription factors function cooperatively. These
ﬁndings highlight that there is still a signiﬁcant challenge remain-
ing to understand the complexities of the dynamic molecular
interactions between the known genetic networks involved in VM
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